Los Angeles Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.44M | Sell |
342,293
-166,954
| -33% | -$643K | 0.01% | 661 |
|
|
2026
Q1 | $1.79M | Sell |
509,247
-125,084
| -20% | -$513K | 0.01% | 530 |
|
|
2025
Q4 | $951K | Sell |
634,331
-495,721
| -44% | -$1.29M | ﹤0.01% | 642 |
|
|
2025
Q3 | $1.48M | Sell |
1,130,052
-81,103
| -7% | -$83.9K | 0.01% | 589 |
|
|
2025
Q2 | $869K | Buy |
1,211,155
+523,368
| +76% | +$411K | ﹤0.01% | 688 |
|
|
2025
Q1 | $1.01M | Buy |
687,787
+356,087
| +107% | +$848K | ﹤0.01% | 564 |
|
|
2024
Q4 | $1.47M | Buy |
331,700
+319,528
| +2,625% | +$1.3M | 0.01% | 509 |
|
|
2024
Q3 | $50.1K | Sell |
12,172
-24,674
| -67% | -$133K | ﹤0.01% | 1150 |
|
|
2024
Q2 | $240K | Sell |
36,846
-48,497
| -57% | -$343K | ﹤0.01% | 1083 |
|
|
2024
Q1 | $743K | Buy |
85,343
+57,806
| +210% | +$701K | ﹤0.01% | 774 |
|
|
2023
Q4 | $315K | Sell |
27,537
-22,978
| -45% | -$227K | ﹤0.01% | 1006 |
|
|
2023
Q3 | $486K | Sell |
50,515
-164,146
| -76% | -$1.61M | ﹤0.01% | 830 |
|
|
2023
Q2 | $2.28M | Buy |
214,661
+22,105
| +11% | +$238K | 0.01% | 461 |
|
|
2023
Q1 | $2.03M | Sell |
192,556
-8,789
| -4% | -$98.5K | 0.01% | 498 |
|
|
2022
Q4 | $2.49M | Buy |
201,345
+48,037
| +31% | +$545K | 0.01% | 463 |
|
|
2022
Q3 | $1.59M | Buy |
153,308
+93,835
| +158% | +$1.06M | 0.01% | 563 |
|
|
2022
Q2 | $686K | Hold |
59,473
| – | – | ﹤0.01% | 851 |
|
|
2022
Q1 | $748K | Hold |
59,473
| – | – | ﹤0.01% | 875 |
|
|
2021
Q4 | $693K | Sell |
59,473
-674
| -1% | -$8.27K | ﹤0.01% | 863 |
|
|
2021
Q3 | $786K | Buy |
60,147
+2,360
| +4% | +$30.5K | ﹤0.01% | 856 |
|
|
2021
Q2 | $744K | Sell |
57,787
-3,255
| -5% | -$37.3K | ﹤0.01% | 992 |
|
|
2021
Q1 | $682K | Sell |
61,042
-81,300
| -57% | -$859K | ﹤0.01% | 1079 |
|
|
2020
Q4 | $1.62M | Sell |
142,342
-898
| -0.6% | -$9.83K | 0.01% | 738 |
|
|
2020
Q3 | $1.29M | Sell |
143,240
-14,018
| -9% | -$139K | 0.01% | 725 |
|
|
2020
Q2 | $1.62M | Buy |
157,258
+5,482
| +4% | +$56.1K | 0.01% | 680 |
|
|
2020
Q1 | $1.53M | Buy |
151,776
+29,095
| +24% | +$342K | 0.01% | 608 |
|
|
2019
Q4 | $1.63M | Buy |
122,681
+45,584
| +59% | +$503K | 0.01% | 698 |
|
|
2019
Q3 | $662K | Hold |
77,097
| – | – | ﹤0.01% | 912 |
|
|
2019
Q2 | $843K | Buy |
77,097
+14,111
| +22% | +$158K | ﹤0.01% | 892 |
|
|
2019
Q1 | $714K | Buy |
+62,986
| New | +$703K | ﹤0.01% | 975 |
|
|
2018
Q3 | – | Sell |
-19,480
| Closed | -$312K | – | 1431 |
|
|
2018
Q2 | $312K | Sell |
19,480
-30,811
| -61% | -$456K | ﹤0.01% | 1274 |
|
|
2018
Q1 | $650K | Buy |
+50,291
| New | +$627K | ﹤0.01% | 954 |
|
Other funds holding IRWD
AC
SCM
Los Angeles Capital Management's IRWD Position: Q2 2026 in Review
Los Angeles Capital Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 33% in Q2 2026, selling an estimated $643K and leaving 342,293 shares worth $1.44M. The position accounts for 0.01% of the portfolio, ranked #661.
Los Angeles Capital Management first reported a position in IRWD in Q1 2018 and has held it in 32 quarters since. The position peaked at $2.49M in Q4 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.
- Los Angeles Capital Management held 342,293 shares of Ironwood Pharmaceuticals worth $1.44M as of Q2 2026.
- Los Angeles Capital Management sold 166,954 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $643K.
- Ironwood Pharmaceuticals made up 0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #661 holding.
- Los Angeles Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2018 and has held it in 32 quarters since.
- Los Angeles Capital Management's Ironwood Pharmaceuticals position peaked at $2.49M in Q4 2022.
- 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.